SCHEMBL25812427

SCHEMBL25812427

O=C(O)c1cnn2cc(Br)cc(O)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
AKR1C1 Q04828 2/20 0.36
AKR1C4 P17516 1/20 0.36
KDM4E B2RXH2 3/20 0.33
POLB P06746 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HCAR2 Q8TDS4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
NR4A3 Q92570 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GLA P06280 1/20 0.32
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA7 P43166 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24329436 0.87 AKR1C3 (0.38) AKR1C3AKR1C2AKR1C1AKR1C4KDM4E
SCHEMBL29066241 0.83 RXFP1 (0.43) KDM4EALDH1A1NR4A3RXFP1MYC
SCHEMBL16914065 0.83 KDM4E (0.41) AKR1C3AKR1C2AKR1C1AKR1C4KDM4E
SCHEMBL31393109 0.83 PLAU (0.38) AKR1C3AKR1C2AKR1C1AKR1C4KDM4E
SCHEMBL23501194 0.82 ALDH1A1 (0.38) ALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL23509916 0.82 NPC1 (0.35) SMN1; SMN2
SCHEMBL20887480 0.79 LCK (0.44) KDM4EALDH1A1MYCPTPN1
SCHEMBL23501196 0.79 MAPK14 (0.38) KDM4EPOLBALDH1A1MAPTSMN1; SMN2
SCHEMBL23501291 0.79 TSHR (0.44) KDM4EALDH1A1MAPTSMN1; SMN2CA12
SCHEMBL25812401 0.79 ALOX5 (0.40) ALDH1A1SMN1; SMN2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-07-13 US disclosed
WO-2021115457-A9 PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 深圳众格生物科技有限公司 2022-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF RET, GRK4, RIN1 AKR1C3 2675/4885AKR1C2 1597/4885AKR1C1 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.